Ward, Simon ![]() |
Abstract
This article highlights recent advances in the discovery of new agonists, antagonists and partial agonists of the 5-HT1D receptor. The field of 5-HT1D agonists continues to deliver a number of new potential therapeutic agents, although advances in this field are now more focussed on the clinical evaluation phase. The identification of novel compounds is greater for the 5-HT1D receptor antagonists, and whilst few truly selective ligands have been identified, a number of approaches are discussed towards defined mixed-pharmacology profiles. An overview is also given of recent advances in biological and clinical understanding of the receptor.
Item Type: | Article |
---|---|
Status: | Published |
Schools: | Medicine |
Uncontrolled Keywords: | 5-HT1D agonist, 5-HT1D antagonist, serotonin receptor, 5-HT receptor |
Publisher: | Bentham Science |
ISSN: | 1568-0266 |
Last Modified: | 23 Oct 2022 12:59 |
URI: | https://orca.cardiff.ac.uk/id/eprint/109344 |
Citation Data
Cited 2 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]() |
Edit Item |